Skip to main navigation Skip to search Skip to main content

Timing and Characteristics of Drug Resistance Mutations (DRMs) in Chronic Hepatitis C Patients During and After Treatment with Protease Inhibitor Therapy at a Single Centre

C. Velazquez, M. Macartney, D. Irish, S. Tanwar, P. Trembling, B. Hogan, J. Catt, S. Glasgow, M. Ju, M.t. Moore, M. Hains, B. Smith, D. Suri, M.g. Jacobs, J. Oben, P. Smith, C. Booth, S. Bridge, A. Garcia, A. MccormickE. Nastouli, G.M. Dusheiko, W. Rosenberg, T. Haque

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)S497
    JournalJournal of Hepatology
    Volume58
    DOIs
    Publication statusPublished - 1 Apr 2013

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Cite this